OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly
Titel:
OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly
Auteur:
Trainer, P.J. Newell-Price, J. Ayuk, J. Aylwin, S. Drake, W.M. Rees, A. Chanson, P. Brue, T. Webb, S.M. Fajardo, C. Aller, J. McCormack, A. Torpy, D.J. Tachas, G. Atley, L.M. Bidlingmaier, M.